• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
    All News #Library
    Biotech

    Design Therapeutics Reports Q4 2025 Financial Results

    GLOBENEWSWIRE

    Design Therapeutics To Join Investor Conferences

    GLOBENEWSWIRE

    Design Therapeutics To Join Investor Conferences

    GLOBENEWSWIRE

    Design Therapeutics To Start DT-818 Dosing In DM1 Patients By H1

    GLOBENEWSWIRE

    Design Therapeutics Appoints Justin Gover to Board of Directors

    GLOBENEWSWIRE

    Design Therapeutics to Present at 2025 Cantor Global Conference

    GLOBENEWSWIRE

    Design Therapeutics Reports Progress in Lead GeneTAC® Programs

    GLOBENEWSWIRE

    Design Therapeutics Begin Ex-U.S. Dosing in FA Ph1/2 DT-216 Trial

    GLOBENEWSWIRE

    Design Therapeutics to Join Jefferies Global Health Conference

    GLOBENEWSWIRE

    Design Therapeutics to Join 2025 RBC Capital Markets Conference

    GLOBENEWSWIRE

    Design Therapeutics Highlights Lead GeneTAC Programs and Q1 2025

    GLOBENEWSWIRE

    Design Therapeutics Reports Positive Phase 1 Data for DT-168

    GLOBENEWSWIRE

    Design Therapeutics to Present Phase 1 Data for Fuchs Endothelial

    GLOBENEWSWIRE

    Design Therapeutics Names Chris Storgard, CMO

    GLOBENEWSWIRE

    Design Highlights GeneTAC Progress, Reports Q4, Full-Year 2024

    GLOBENEWSWIRE

    Design To Join Leerink’s Global Healthcare Conference

    GLOBENEWSWIRE

    Design Therapeutics to Attend Multiple Investor Conferences

    GLOBENEWSWIRE

    Design Therapeutics Q3 2024 Results & GeneTACTM Milestones

    GLOBENEWSWIRE

    Design Therapeutics To Attend Cantor Healthcare Conference

    GLOBENEWSWIRE

    Design Therapeutics Reports Q2 2024 Results And GeneTAC™ Milestones

    GLOBENEWSWIRE

    Design Reports Initial Results from Phase 1 Study of DT-216

    GLOBENEWSWIRE

    Design Therapeutics Reports Second Quarter 2023 Financial Results

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.